Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Depression, alcohol use and adherence to antiretroviral therapy in sub-Saharan Africa: a systematic review.

Nakimuli-Mpungu E, Bass JK, Alexandre P, Mills EJ, Musisi S, Ram M, Katabira E, Nachega JB.

AIDS Behav. 2012 Nov;16(8):2101-18. doi: 10.1007/s10461-011-0087-8. Review.

PMID:
22116638
2.

Patterns and predictors of antiretroviral therapy use among alcohol drinkers at HIV clinics in Tshwane, South Africa.

Kekwaletswe CT, Morojele NK.

AIDS Care. 2014;26 Suppl 1:S78-82. doi: 10.1080/09540121.2014.906558. Epub 2014 Apr 14.

PMID:
24731102
3.

Medication adherence in HIV-infected smokers: the mediating role of depressive symptoms.

Webb MS, Vanable PA, Carey MP, Blair DC.

AIDS Educ Prev. 2009 Jun;21(3 Suppl):94-105. doi: 10.1521/aeap.2009.21.3_supp.94.

PMID:
19537957
4.

Adherence to and effectiveness of highly active antiretroviral treatment for HIV infection: assessing the bidirectional relationship.

Lamiraud K, Moatti JP, Raffi F, Carrieri MP, Protopopescu C, Michelet C, Schneider L, Collin F, Leport C, Spire B.

Med Care. 2012 May;50(5):410-8. doi: 10.1097/MLR.0b013e3182422f61.

PMID:
22362167
5.

Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis.

Malta M, Magnanini MM, Strathdee SA, Bastos FI.

AIDS Behav. 2010 Aug;14(4):731-47. doi: 10.1007/s10461-008-9489-7. Epub 2008 Nov 20.

PMID:
19020970
6.

Lifetime depressive disorders and adherence to anti-retroviral therapy in HIV-infected Ugandan adults: a case-control study.

Nakimuli-Mpungu E, Mojtabai R, Alexandre PK, Musisi S, Katabira E, Nachega JB, Treisman G, Bass JK.

J Affect Disord. 2013 Feb 20;145(2):221-6. doi: 10.1016/j.jad.2012.08.002. Epub 2012 Sep 25.

PMID:
23017542
7.

Predicting adherence to antiretroviral therapy in HIV-infected older adults: the moderating role of gender.

Bianco JA, Heckman TG, Sutton M, Watakakosol R, Lovejoy T.

AIDS Behav. 2011 Oct;15(7):1437-46. doi: 10.1007/s10461-010-9756-2.

PMID:
20632080
8.

Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries: a systematic review and meta-analysis.

Uthman OA, Magidson JF, Safren SA, Nachega JB.

Curr HIV/AIDS Rep. 2014 Sep;11(3):291-307. doi: 10.1007/s11904-014-0220-1. Review.

9.

Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis.

Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, Rachlis B, Wu P, Cooper C, Thabane L, Wilson K, Guyatt GH, Bangsberg DR.

JAMA. 2006 Aug 9;296(6):679-90. Review.

PMID:
16896111
10.

Adherence to antiretroviral therapy: factors independently associated with reported difficulty taking antiretroviral therapy in a national sample of HIV-positive Australians.

Grierson J, Koelmeyer RL, Smith A, Pitts M.

HIV Med. 2011 Oct;12(9):562-9. doi: 10.1111/j.1468-1293.2011.00928.x. Epub 2011 May 9.

11.

Adherence to highly active antiretroviral therapy (HAART): a meta-analysis.

Ortego C, Huedo-Medina TB, Llorca J, Sevilla L, Santos P, Rodríguez E, Warren MR, Vejo J.

AIDS Behav. 2011 Oct;15(7):1381-96. doi: 10.1007/s10461-011-9942-x.

PMID:
21468660
12.

Alcohol-antiretroviral therapy interactive toxicity beliefs and daily medication adherence and alcohol use among people living with HIV.

Pellowski JA, Kalichman SC, Kalichman MO, Cherry C.

AIDS Care. 2016 Aug;28(8):963-70. doi: 10.1080/09540121.2016.1154134. Epub 2016 Mar 10.

13.

Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review.

Adejumo OA, Malee KM, Ryscavage P, Hunter SJ, Taiwo BO.

J Int AIDS Soc. 2015 Sep 16;18:20049. doi: 10.7448/IAS.18.1.20049. eCollection 2015. Review.

14.

Patient-reported barriers and drivers of adherence to antiretrovirals in sub-Saharan Africa: a meta-ethnography.

Merten S, Kenter E, McKenzie O, Musheke M, Ntalasha H, Martin-Hilber A.

Trop Med Int Health. 2010 Jun;15 Suppl 1:16-33. doi: 10.1111/j.1365-3156.2010.02510.x. Review.

15.

Barriers to antiretroviral adherence in HIV-positive patients receiving free medication in Kayunga, Uganda.

Senkomago V, Guwatudde D, Breda M, Khoshnood K.

AIDS Care. 2011 Oct;23(10):1246-53. doi: 10.1080/09540121.2011.564112. Epub 2011 Jun 21.

PMID:
21939403
16.
17.

Depression, substance abuse and other contextual predictors of adherence to antiretroviral therapy (ART) among Haitians.

Malow R, Dévieux JG, Stein JA, Rosenberg R, Jean-Gilles M, Attonito J, Koenig SP, Raviola G, Sévère P, Pape JW.

AIDS Behav. 2013 May;17(4):1221-30. doi: 10.1007/s10461-012-0400-1.

PMID:
23338563
18.

Factors associated with adherence to highly active antiretroviral therapy in homeless or unstably housed adults living with HIV.

Royal SW, Kidder DP, Patrabansh S, Wolitski RJ, Holtgrave DR, Aidala A, Pals S, Stall R.

AIDS Care. 2009 Apr;21(4):448-55. doi: 10.1080/09540120802270250.

PMID:
19401865
19.

Highly active antiretroviral therapy adherence and its determinants in selected hospitals from south and central Ethiopia.

Beyene KA, Gedif T, Gebre-Mariam T, Engidawork E.

Pharmacoepidemiol Drug Saf. 2009 Nov;18(11):1007-15. doi: 10.1002/pds.1814.

PMID:
19650153
20.

Psychosocial factors affecting medication adherence among HIV-1 infected adults receiving combination antiretroviral therapy (cART) in Botswana.

Do NT, Phiri K, Bussmann H, Gaolathe T, Marlink RG, Wester CW.

AIDS Res Hum Retroviruses. 2010 Jun;26(6):685-91. doi: 10.1089/aid.2009.0222.

Supplemental Content

Support Center